论文部分内容阅读
SRS经历了40余年的发展,治疗了15000余例各种颅内疾病,对不能手术或手术效果不好的脑血管疾病和良恶性肿癌取得了较好疗效.目前使用的γ刀和?中心直线加速器各有长短,前者更准确后者易普及.随着临床病理研究的深入,可望提出一个副作用最小疗效最佳的剂量标准.SRS的适应症是有限的,在一些情况下它只能作为一种补充治疗手段,不能取代常规开颅手术和其他治疗.
SRS has experienced more than 40 years of development, has treated more than 15,000 cases of various intracranial diseases, and has achieved good curative effect on cerebrovascular diseases and benign or malignant tumors that are inoperable or have poor surgical results. Currently used gamma knife and center line Accelerators have different lengths, the former being more accurate and the latter being more readily available. With the deepening of clinical pathology studies, it is expected to propose a dose standard with minimal side effects and the best efficacy. SRS indications are limited, in some cases it can only be used as A supplementary treatment can not replace the conventional craniotomy and other treatments.